Analysis and Commentary
An independent investor’s view beneath the surface of financial statements, macroeconomics, and geopolitics. No market noise or fast stock tips. Only deep analysis and context with a clear timestamp.
- Date: August 15, 2026
BioMarin raised its outlook. It only raised one part of...
BioMarin’s second quarter sent the stock up sixteen percent in three trading days. Revenue rose a fifth to $990 million, earnings beat expectations by...
- Date: August 15, 2026
Zeta raised guidance for the twentieth time. The number that...
Zeta Global reported its twentieth consecutive quarter of beating its own guidance and raising it. Revenue grew 44 percent to $443 million, the company...
- Date: August 13, 2026
The worst case has lasted six months. Oil is at...
In mid-March 2026, the Strait of Hormuz had been shut for two weeks and Brent traded above $106. FGE was talking about a $150–200...